Subtleties in practical application of prolonged infusion of β-lactam antibiotics

International Journal of Antimicrobial Agents

Volumn 45, Issue 5, 2015, Pages 461-463

  De Waele, Jan J ^a   Lipman, Jeffrey ^b,c   Carlier, Mieke ^a,d   Roberts, Jason A ^b,c,e  

^a GHENT UNIVERSITY HOSPITAL   (Belgium)

^b UNIVERSITY OF QUEENSLAND   (Australia)

^c ROYAL BRISBANE AND WOMEN'S HOSPITAL   (Australia)

^d GHENT UNIVERSITY   (Belgium)

^e UNIVERSITY OF LIVERPOOL   (United Kingdom)

Author keywords

Antibiotics continuous infusion; Prolonged infusion; Lactam

Indexed keywords

ANTIINFECTIVE AGENT; BETA LACTAM;

BACTERIAL INFECTIONS; HUMAN; INTRAVENOUS DRUG ADMINISTRATION; PROCEDURES;

ANTI-BACTERIAL AGENTS; BACTERIAL INFECTIONS; BETA-LACTAMS; HUMANS; INFUSIONS, INTRAVENOUS;

EID: 84939939427     PISSN: 09248579     EISSN: 18727913     Source Type: Journal    
DOI: 10.1016/j.ijantimicag.2015.01.007     Document Type: Note

References (19)

1. R.P. Dellinger, M.M. Levy, A. Rhodes, D. Annane, H. Gerlach, and S.M. Opal et al. Surviving Sepsis Campaign: international guidelines for management of severe sepsis and septic shock, 2012 Intensive Care Medicine 39 2013 165 228
2. J.A. Roberts, G.M. Joynt, G.Y. Choi, C.D. Gomersall, and J. Lipman How to optimise antimicrobial prescriptions in the intensive care unit: principles of individualised dosing using pharmacokinetics and pharmacodynamics Int J Antimicrob Agents 39 2012 187 192
3. A.A. Udy, J.A. Roberts, J.J. De Waele, D.L. Paterson, and J. Lipman What's behind the failure of emerging antibiotics in the critically ill? Understanding the impact of altered pharmacokinetics and augmented renal clearance Int J Antimicrob Agents 39 2012 455 457
4. J.A. Roberts, S.K. Paul, M. Akova, M. Bassetti, J.J. De Waele, G. Dimopoulos DALI Study DALI: Defining Antibiotic Levels in Intensive care unit patients: are current β-lactam antibiotic doses sufficient for critically ill patients? Clin Infect Dis 58 2014 1072 1083
5. M.H. Abdul-Aziz, J.M. Dulhunty, R. Bellomo, J. Lipman, and J.A. Roberts Continuous β-lactam infusion in critically ill patients: the clinical evidence Ann Intensive Care 2 2012 37
6. J.J. De Waele, J. Lipman, M. Akova, M. Bassetti, G. Dimopoulos, and M. Kaukonen et al. Risk factors for target non-attainment during empirical treatment with β-lactam antibiotics in critically ill patients Intensive Care Medicine 40 2014 1340 1351
7. J.A. Roberts, S. Webb, D. Paterson, K.M. Ho, and J. Lipman A systematic review on clinical benefits of continuous administration of β-lactam antibiotics Crit Care Med 37 2009 2071 2078
8. M. Lips, M. Siller, J. Strojil, K. Urbanek, M. Balik, and H. Suchankova Pharmacokinetics of imipenem in critically ill patients during empirical treatment of nosocomial pneumonia: a comparison of 0.5-h and 3-h infusions Int J Antimicrob Agents 44 2014 358 362
9. J. Teo, Y. Liew, W. Lee, and A.L. Kwa Prolonged infusion versus intermittent boluses of β-lactam antibiotics for treatment of acute infections: a meta-analysis Int J Antimicrob Agents 43 2014 403 411
10. G.S. Casu, M. Hites, F. Jacobs, F. Cotton, F. Wolff, and M. Beumier et al. Can changes in renal function predict variations in β-lactam concentrations in septic patients? Int J Antimicrob Agents 42 2013 422 428
11. J.M. Dulhunty, J.A. Roberts, J.S. Davis, S.A. Webb, R. Bellomo, and C. Gomersall et al. Continuous infusion of β-lactam antibiotics in severe sepsis: a multicenter double-blind, randomized controlled trial Clin Infect Dis 56 2013 236 244
12. S.H. MacVane, J.L. Kuti, and D.P. Nicolau Prolonging β-lactam infusion: a review of the rationale and evidence, and guidance for implementation Int J Antimicrob Agents 43 2014 105 113
13. J.A. Roberts, and J. Lipman Pharmacokinetic issues for antibiotics in the critically ill patient Crit Care Med 37 2009 840 851 (quiz 859)
14. J.J. De Waele, I. Danneels, P. Depuydt, J. Decruyenaere, M. Bourgeois, and E. Hoste Factors associated with inadequate early vancomycin levels in critically ill patients treated with continuous infusion Int J Antimicrob Agents 41 2013 434 438
15. J.A. Roberts, F.S. Taccone, A.A. Udy, J.L. Vincent, F. Jacobs, and J. Lipman Vancomycin dosing in critically ill patients: robust methods for improved continuous-infusion regimens Antimicrob Agents Chemother 55 2011 2704 2709
16. A.A. Udy, J. Lipman, P. Jarrett, K. Klein, S.C. Wallis, and K. Patel et al. Are standard doses of piperacillin sufficient for critically ill patients with augmented renal clearance? Crit Care 2015 [Epub ahead of print]
17. Carlier M, Stove V, Verstraete AG, De Waele J. Stability of generic brands of meropenem reconstituted in isotonic saline. Minerva Anestesiol 2014 Sep 15 [Epub ahead of print].
18. B. Claus, F. Buyle, H. Robays, and D. Vogelaers Importance of infusion volume and pump characteristics in extended administration of β-lactam antibiotics Antimicrob Agents Chemother 54 2010 4950
19. C. Adembri, R. Ristori, C. Chelazzi, S. Arrigucci, M.I. Cassetta, and A.R. De Gaudio et al. Cefazolin bolus and continuous administration for elective cardiac surgery: improved pharmacokinetic and pharmacodynamic parameters J Thorac Cardiovasc Surg 140 2010 471 475